We have previously determined frequencies of different CD4+ T cell subsets in peripheral blood mononuclear cells (PBMCs), normal tissue-infiltrating lymphocytes (NILs), and tumor-infiltrating lymphocytes (TILs) of CRC patients [7]. This evidence concerns the gene CD4 and neoplasm.